VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
VolitionRX Limited (VNRX)
NASDAQ:AMEX Investor Relations:
ir.volitionrx.com
Company Research
Source: Yahoo! Finance
Operating Expenses: Reduced by $4.8 million, a 17% decrease compared to 2024. Net Cash Used in Operating Activities: $19.7 million in 2025, down from $25.9 million in 2024. Cash and Cash Equivalents: Approximately $1.1 million at the end of 2025. Additional Funding: $5.4 million from ATM facility and $1.9 million from a convertible note post-year-end. Nondilutive Funding: $2.3 million from the Walloon Region in Belgium, totaling over $25 million from inception. Warning! GuruFocus has detected 7 Warning Signs with VNRX. Is VNRX fairly valued? Test your thesis with our free DCF calculator. Release Date: April 01, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points VolitionRX Ltd ( VNRX ) received its first order for the Nu.Q Cancer assays for clinical certification in lung cancer, marking a significant step towards routine clinical use. The company announced the inclusion of its Nu.Q NETs assay i
Show less
Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNRX alerts
High impacting VolitionRX Limited news events
Weekly update
A roundup of the hottest topics
VNRX
News
- VolitionRx Limited (VNRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- VolitionRx krijgt 2,0 miljoen EUR aan niet-verwaterende financiering van regionale overheidsinstanties in BelgiëPR Newswire
- VolitionRX reports FY results [Seeking Alpha]Seeking Alpha
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update [Yahoo! Finance]Yahoo! Finance
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update [TheStreet.com]TheStreet.com
VNRX
Earnings
- 3/31/26 - Miss
VNRX
Sec Filings
- 4/1/26 - Form 8-K
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- VNRX's page on the SEC website